BIOJETAY
Live / Applied — New application — assigned to an examiner (as of 01 Sept 2026)
What this means for you
Not registered yet, but its 27 Apr 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99789756
- Mark type
- Word mark
- Filed
- 27 Apr 2026
- Attorney of record
- Jonathan M. Rixen
Goods and services
- Class 005 — Pharmaceuticals: medicines for human purposes for the treatment of hematological diseases; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, cardiovascular, hematologic, genitourinary, tumors, ophthalmic, respiratory, neurological, gastrointestinal diseases, coagulation or bleeding disorders, diseases of the blood and blood-forming organs, immune system related diseases, congenital bleeding disorders or acquired bleeding disorders, disorders due to a deficiency or presence of coagulation factors, hemophilia, disorders resulting from anticoagulant therapy, bleeding associated with trauma and injury; diagnostic preparations for medical purposes; dietetic foods and beverages adapted for medical use; depuratives for the body; veterinary pharmaceutical compounds for the treatment of hematological diseases; pesticides; first aid kits; dental abrasives
Owner
- JIANGSU BIOJETAY BIOTECHNOLOGY CO., LTD., Wuxi, Jiangsu, CN
Prosecution history
- 01 Sept 2026 — ASSIGNED TO EXAMINER
- 30 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 27 Apr 2026 — NEW APPLICATION ENTERED